icon-folder.gif   Conference Reports for NATAP  
 
  63rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 9-12 2012
Back grey_arrow_rt.gif
 
 
 
Peginterferon Lambda-1a (Lambda) Compared With Peginterferon Alfa-2a (Alfa) in Treatment-Naive Patients With HCV Genotypes 1 or 4: SVR24 Results From EMERGE Phase 2b
 
 
  Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
 
Muir A1 for the EMERGE Study Group; Hillson J,2 Gray T,2 Xu D,3 Ishak L,2 Freeman J,2 Fontana D,2 Horga A,3 Lopez-Talavera JC3 1Duke University Medical Center, Durham, NC; 2ZymoGenetics, Bristol-Myers Squibb, Seattle, WA; 3Research and Development, Bristol-Myers Squibb, Wallingford, CT

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif